Anticoagulant treatment of pulmonary embolism: impact and implications of the EINSTEIN PE study (Q34640824)

3 August 2017

title

Anticoagulant treatment of pulmonary embolism: impact and implications of the EINSTEIN PE study (English)

1 reference

3 August 2017

1 reference

1 reference

Paolo Prandoni

1

1 reference

3 August 2017

language of work or name

1 reference

25 August 2012

1 reference

European Journal of Haematology

3 August 2017

published in

1 reference

3 August 2017

volume

89

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

281-287

1 reference

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

3 August 2017

cites work

1 reference

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

21 January 2018

1 reference

Strategies for diagnosis and prevention of venous thromboembolism during pregnancy

21 January 2018

1 reference

Natural history of venous thromboembolism

21 January 2018

1 reference

Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review

21 January 2018

1 reference

Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)

21 January 2018

1 reference

Estimated case fatality rate of pulmonary embolism, 1979 to 1998.

21 January 2018

1 reference

The incidence of recurrent venous thromboembolism and chronic thromboembolic pulmonary hypertension following a first episode of pulmonary embolism

21 January 2018

1 reference

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study

21 January 2018

1 reference

Extended oral anticoagulant therapy after a first episode of pulmonary embolism.

21 January 2018

1 reference

Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

21 January 2018

1 reference

Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)

21 January 2018

1 reference

Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry

21 January 2018

1 reference

Clinical presentation of acute pulmonary embolism: survey of 800 cases

21 January 2018

1 reference

21 January 2018

Acute pulmonary embolism

1 reference

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism

21 January 2018

1 reference

Idraparinux versus standard therapy for venous thromboembolic disease

21 January 2018

1 reference

Extended prophylaxis of venous thromboembolism with idraparinux

21 January 2018

1 reference

New anticoagulants - promising and failed developments.

21 January 2018

1 reference

Reversibility of the anti-FXa activity of idrabiotaparinux (biotinylated idraparinux) by intravenous avidin infusion

21 January 2018

1 reference

Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial

21 January 2018

1 reference

Oral rivaroxaban for symptomatic venous thromboembolism

21 January 2018

1 reference

Dabigatran versus warfarin in the treatment of acute venous thromboembolism

21 January 2018

1 reference

Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials

21 January 2018

1 reference

Oral rivaroxaban for the treatment of symptomatic pulmonary embolism

21 January 2018

1 reference

VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer

21 January 2018

1 reference

Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study

21 January 2018

1 reference

Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EJH.12002

1 reference

3 August 2017

1 reference